课题基金 / 基金详情

Contrast US Guided RF Ablation for Prostate Cancer

Contrast US Guided RF Ablation for Prostate Cancer
对比美国引导射频消融治疗前列腺癌
批准号:
6734815
负责人:
Ji-Bin Liu
金额:
$18.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-20 至 2005-08-31

项目摘要

项目成果

Ji-Bin Liu的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 鉴于前列腺癌的多病灶性质,局部前列腺癌的治疗需要破坏整个腺体。放射治疗和根治性直肠癌切除术是有效的治疗方法,但与显着的发病率。为了最大限度地减少前列腺癌治疗的并发症,必须探索新的局部前列腺癌微创替代治疗方法,以破坏所有有活力的前列腺组织和肿瘤。射频热消融已在临床上用于治疗肝脏和全身其他肿瘤。然而,该技术尚未被充分研究用于前列腺肿瘤的消融。射频(RF)治疗临床应用的一个主要挑战是我们无法在消融过程中区分存活组织/肿瘤和坏死组织。缺乏这种定义可能导致过度治疗或治疗不足。尽管超声用于引导针放置,但灰阶和多普勒成像的常规超声检查结果不能识别残留的活组织/肿瘤。我们建议利用超声造影剂来检测前列腺中的肿瘤微血管和实质血流。基于前列腺癌的生物学行为和我们的初步研究,我们提出:(1)治疗前列腺癌的新治疗策略-全前列腺射频消融,(2)监测前列腺消融的独特成像模式-超声造影。本研究的目的是优化经直肠超声造影引导和监测全前列腺消融治疗前列腺癌。超声造影成像将有助于在整个前列腺的射频消融过程中检测有活力的前列腺组织。对比度增强成像将使我们能够使用最小的必要能量来实现安全,微创的前列腺癌消融术。该项目的具体目标是(1)使用对比增强经直肠超声(TRUS)监测和指导动物模型中整个前列腺的射频消融,(2)探索在射频治疗期间保护前列腺尿道和周围结构的方法,以及(3)建立射频参数,以优化前列腺的破坏,同时最大限度地减少对周围组织的损伤。实验将分三个连续阶段进行:(1)建立射频消融参数以消融整个前列腺并优化对比增强成像的程序以监测射频消融,(2)建立冷却参数以保护相邻的重要结构,(3)为测试对比的有效性和一致性-增强TRUS以引导整个前列腺的射频消融,同时消除对邻近器官的损伤。超声的横截面和体积数据将与病理学结果相关联。我们将证明,前列腺的对比度增强成像可以优化前列腺的射频消融,以供将来在人类中作为前列腺癌的创新治疗。
英文摘要
DESCRIPTION (provided by applicant): Given the multi-focal nature of prostate cancer, treatment of localized prostate cancer requires destruction of the entire gland. Radiation therapy and radical prostatectomy are effective treatment, but are associated with significant morbidity. In order to minimize the complications of therapy for prostate cancer, new less invasive alternative treatments for localized prostate cancer must be explored to destroy all viable prostatic tissue and tumor. Radiofrequency thermal ablation has been used clinically for treatment of hepatic and other tumors throughout the body. However, this technique has not been fully investigated for the ablation of prostate tumors. A major challenge to clinical application of radiofrequency (RF) therapy is our inability to distinguish viable tissue/tumor from necrotic tissue during ablation. Lack of such definition may lead to over-treatment or under-treatment. Although ultrasound is used for guiding needle placement, conventional sonographic findings of gray scale and Doppler imaging cannot identify residual viable tissue/tumor. We propose to utilize ultrasound contrast agents to detect tumor microvasculature and parenchymal blood flow in the prostate. Based on the biological behavior of prostate cancer and our preliminary studies, we propose: (1) A new therapeutic strategy for the treatment of prostate cancer - RF ablation of the whole prostate, (2) A unique imaging modality for monitoring ablation of the prostate gland - contrast-enhanced sonography. The objective of the study is to optimize transrectal contrast-enhanced ultrasound for guidance and monitoring of whole prostate ablation for the treatment of prostate cancer. Contrast-enhanced sonographic imaging will facilitate detection of viable prostate tissue during RF ablation of the entire prostate gland. Contrast-enhanced imaging will allow us to use the minimum necessary energy to achieve a safe, minimally invasive ablation of prostate cancer. The specific aims of this project are (1) to use contrast-enhanced transrectal ultrasound (TRUS) to monitor and direct RF ablation of the entire prostate in an animal model, (2) to explore methods to protect the prostatic urethra and surrounding structures during RF therapy and (3) to establish RF parameters to optimize destruction of the prostate gland and simultaneously minimize damage to the surrounding tissues. Experiments will be performed in three sequential phases: (1) To establish the RF ablation parameters to ablate the entire prostate and to optimize procedures for contrastenhanced imaging to monitor RF ablation, (2) To establish cooling parameters to protect adjacent vital structures, (3) To test the effectiveness and consistency of contrast-enhanced TRUS to guide RF ablation of the entire prostate while eliminating damage to adjacent organs. Cross-sectional and volume data on ultrasound will be correlated with results on pathology. We will demonstrate that contrast-enhanced imaging of the prostate can optimize RF ablation of the prostate for future use in humans as an innovative treatment of prostate cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Detection of sentinel lymph nodes in female lower genital tract cancer patients with contrast-enhanced ultrasound imaging
  • 批准号:
    10455413
  • 项目类别:
  • 资助金额:
    $17.87万
  • 财政年份:
    2021
  • 负责人:
    Ji-Bin Liu
  • 依托单位:
Contrast US Guided RF Ablation for Prostate Cancer
  • 批准号:
    6802029
  • 项目类别:
  • 资助金额:
    $23.55万
  • 财政年份:
    2003
  • 负责人:
    Ji-Bin Liu
  • 依托单位:
TUMOR EVALUATION BY ENDOLUMINAL 2D AND 3D ULTRASOUND
  • 批准号:
    2105381
  • 项目类别:
  • 资助金额:
    $6.44万
  • 财政年份:
    1995
  • 负责人:
    Ji-Bin Liu
  • 依托单位:
TUMOR EVALUATION BY ENDOLUMINAL 2D AND 3D ULTRASOUND
  • 批准号:
    2545359
  • 项目类别:
  • 资助金额:
    $6.84万
  • 财政年份:
    1995
  • 负责人:
    Ji-Bin Liu
  • 依托单位:
海外基金